Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
0.3625
+0.0045 (1.26%)
Apr 1, 2025, 10:38 AM EDT - Market open
Aethlon Medical Employees
Aethlon Medical had 14 employees as of March 31, 2024. The number of employees decreased by 1 or -6.67% compared to the previous year.
Employees
14
Change (1Y)
-1
Growth (1Y)
-6.67%
Revenue / Employee
n/a
Profits / Employee
-$682,758
Market Cap
5.24M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AEMD News
- 22 days ago - Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal - PRNewsWire
- 6 weeks ago - Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025 - PRNewsWire
- 6 weeks ago - Aethlon Medical, Inc. (AEMD) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update - PRNewsWire
- 7 weeks ago - Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025 - PRNewsWire
- 2 months ago - Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial - PRNewsWire
- 3 months ago - Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu - PRNewsWire
- 4 months ago - Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally - Newsfile Corp